This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Weiss, Glen
| Item Type | Name |
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Academic Article
|
Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non-small-cell Lung Cancer.
|
|
Academic Article
|
Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma.
|
|
Academic Article
|
First-In-Human Study of Cemiplimab Alone or In Combination with Radiotherapy and/or Low-dose Cyclophosphamide in Patients with Advanced Malignancies.
|
|
Academic Article
|
Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors.
|
|
Academic Article
|
Phase I Study of Enavatuzumab, a First-in-Class Humanized Monoclonal Antibody Targeting the TWEAK Receptor, in Patients with Advanced Solid Tumors.
|
|
Academic Article
|
Atezolizumab plus Chemotherapy in Small-Cell Lung Cancer.
|
|
Academic Article
|
A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus).
|
|
Academic Article
|
Single-institution experience with pemetrexed and bevacizumab as salvage therapy in advanced non-small-cell lung cancer.
|
|
Academic Article
|
Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose-escalation phase 1 trial.
|
- Antibodies Monoclonal Humanized